# TADALAFIL
> **ANDA208824** · Abbreviated New Drug Application (Generic) · Sponsor: HANGZHOU BINJIANG · Approved 2020-10-27
## Drug
- **FDA Application Number:** ANDA208824
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TADALAFIL
- **Generic name:** TADALAFIL
- **Active ingredients:** TADALAFIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HANGZHOU BINJIANG
- **Manufacturer:** Bostal LLC
- **First approval:** 2020-10-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208824)
---
*AI Analytics · CC0 1.0*